The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology.

Cagney, Daniel N; Sul, Joohee; Huang, Raymond Y; Ligon, Keith L; Wen, Patrick Y; Alexander, Brian M

Cagney, Daniel N; Sul, Joohee; Huang, Raymond Y; Ligon, Keith L; Wen, Patrick Y; Alexander, Brian M.

Afiliação

Cagney DN; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
Sul J; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Huang RY; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Ligon KL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Wen PY; Center For Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.
Alexander BM; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.

Neuro Oncol ; 20(9): 1162-1172, 2018 08 02.

Article em En | MEDLINE | ID: mdl-29294069

Assuntos

Biomarcadores Tumorais/análise; Neoplasias Encefálicas/diagnóstico; Dicionários como Assunto; Neoplasias Encefálicas/terapia; Humanos; National Institutes of Health (U.S.); Estados Unidos; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Biomarcadores Tumorais / Dicionários como Assunto Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google